Drugs Made In America Acquisition II Corp (DMIIU) Kazanmak

Drugs Made In America Acquisition II Corp. operates as a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. While the Company may pursue a business combination target in any business, industry or geographical location, it intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenue to date.